600 cancer patients to help unlock secrets of immunotherapy
NCT ID NCT07427186
First seen Feb 26, 2026 · Last updated May 24, 2026 · Updated 14 times
Summary
This study will follow 600 people with early-stage solid cancers (like lung, head and neck, melanoma, or bladder cancer) who receive immunotherapy before surgery. Researchers will collect blood and tumor samples to find biological markers that show whether the treatment is working. The goal is to better understand why some patients respond well to immunotherapy and others do not, which could improve future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID CANCERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu Rangueil
Toulouse, 31400, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hopital Larrey
Toulouse, 31400, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Universitaire Du Cancer de Toulouse - Oncopole
Toulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.